Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/29423
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2028-08-30
Colecciones
- INI - Artigos de Periódicos [3253]
Metadatos
Mostrar el registro completo del ítem
COMPARATIVE EFFECTIVENESS OF TENOFOVIR IN HIV-INFECTED TREATMENT-EXPERIENCED PATIENTS: SYSTEMATIC REVIEW AND META-ANALYSIS
Autor
Afiliación
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland./ Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland.
Division of Infectious Diseases and Hospital Hygiene , University Hospital Basel , Basel , Switzerland./ Department of Clinical Epidemiology and Biostatistics , McMaster University , Hamilton , Canada.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland./ Department of Clinical Epidemiology and Biostatistics , McMaster University , Hamilton , Canada.
Division of Infectious Diseases and Hospital Hygiene , University Hospital Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland./ Department of Clinical Epidemiology and Biostatistics , McMaster University , Hamilton , Canada./ Department of Clinical Research , University of Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland./ Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland.
Division of Infectious Diseases and Hospital Hygiene , University Hospital Basel , Basel , Switzerland./ Department of Clinical Epidemiology and Biostatistics , McMaster University , Hamilton , Canada.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland./ Department of Clinical Epidemiology and Biostatistics , McMaster University , Hamilton , Canada.
Division of Infectious Diseases and Hospital Hygiene , University Hospital Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland./ Department of Clinical Epidemiology and Biostatistics , McMaster University , Hamilton , Canada./ Department of Clinical Research , University of Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland.
Basel Institute for Clinical Epidemiology & Biostatistics , University Hospital Basel , Basel , Switzerland.
Resumen en ingles
Antiretroviral therapy (ART) regimens for HIV infection are frequently changed. We conducted a systematic review of randomized trials (RCTs) on the benefits and harms of switching to tenofovir disoproxil fumarate (TDF)-based regimens in ART-experienced patients.
Compartir